Krystal Biotech, Inc. Quarterly Operating Income (Loss) in USD from Q3 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Krystal Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2016 to Q3 2024.
  • Krystal Biotech, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $22.4M.
  • Krystal Biotech, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $27.5M.
  • Krystal Biotech, Inc. annual Operating Income (Loss) for 2023 was -$110M, a 24.4% increase from 2022.
  • Krystal Biotech, Inc. annual Operating Income (Loss) for 2022 was -$145M, a 113% decline from 2021.
  • Krystal Biotech, Inc. annual Operating Income (Loss) for 2021 was -$68.3M, a 107% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $27.5M $22.4M +$48.4M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$21M $8.57M +$46.6M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 -$67.6M -$6.68M +$42.1M +86.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$110M $3.14M +$37.9M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 -$148M -$26M +$5.46M +17.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$153M -$38M -$9.3M -32.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 -$144M -$48.8M +$1.4M +2.79% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$145M -$34.8M -$12.9M -58.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 -$132M -$31.5M -$15.8M -101% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$117M -$28.8M -$12.4M -75.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$104M -$50.2M -$35.9M -250% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$68.3M -$21.9M -$11.5M -110% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$56.8M -$15.7M -$5.97M -61.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$50.8M -$16.4M -$9.44M -136% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$41.4M -$14.4M -$8.41M -141% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$33M -$10.4M -$4.26M -69.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$28.7M -$9.68M -$4.34M -81.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$24.4M -$6.95M -$1.06M -18.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$23.3M -$5.95M -$1.25M -26.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$22.1M -$6.16M -$1.94M -45.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$20.1M -$5.34M -$2.37M -79.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$17.8M -$5.89M -$3.44M -141% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$14.3M -$4.69M -$2.42M -106% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 -$11.9M -$4.22M -$2.72M -181% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$9.2M -$2.97M -$879K -42% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 -$8.32M -$2.45M -$1.73M -243% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$6.58M -$2.28M -$1.81M -390% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$4.77M -$1.5M Oct 1, 2017 Dec 31, 2017 10-K 2018-03-12
Q3 2017 -$2.09M -$1.77M -550% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$715K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$465K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q3 2016 -$322K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.